Papaefthymiou, A.; Sarrou, S.; Pateras, K.; Vachliotis, I.D.; Agrotis, G.; Sgantzou, I.-K.; Perifanos, G.; Kapsoritakis, A.; Speletas, M.; Vlychou, M.;
et al. The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial. Pharmaceuticals 2024, 17, 1432.
https://doi.org/10.3390/ph17111432
AMA Style
Papaefthymiou A, Sarrou S, Pateras K, Vachliotis ID, Agrotis G, Sgantzou I-K, Perifanos G, Kapsoritakis A, Speletas M, Vlychou M,
et al. The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial. Pharmaceuticals. 2024; 17(11):1432.
https://doi.org/10.3390/ph17111432
Chicago/Turabian Style
Papaefthymiou, Apostolis, Styliani Sarrou, Konstantinos Pateras, Ilias D. Vachliotis, Georgios Agrotis, Ioanna-Konstantina Sgantzou, Georgios Perifanos, Andreas Kapsoritakis, Matthaios Speletas, Marianna Vlychou,
and et al. 2024. "The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial" Pharmaceuticals 17, no. 11: 1432.
https://doi.org/10.3390/ph17111432
APA Style
Papaefthymiou, A., Sarrou, S., Pateras, K., Vachliotis, I. D., Agrotis, G., Sgantzou, I.-K., Perifanos, G., Kapsoritakis, A., Speletas, M., Vlychou, M., Dalekos, G. N., Potamianos, S., Goulas, A., Kountouras, J., & Polyzos, S. A.
(2024). The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial. Pharmaceuticals, 17(11), 1432.
https://doi.org/10.3390/ph17111432
